Teva Pharmaceutical Industries Aktie
20,50
EUR
+0,10
EUR
+0,49
%
21,07
USD
±0,00
USD
±0,00
%
nachbörslich
Teva Pharmaceutical Industries Aktie Analyse
11.06.19 | Teva Pharmaceutical Industries Underweight | Barclays Capital | |
02.02.18 | Teva Pharmaceutical Industries Sell | BTIG Research | |
03.11.17 | Teva Pharmaceutical Industries Underperform | RBC Capital Markets | |
30.10.17 | Teva Pharmaceutical Industries Underperform | RBC Capital Markets | |
18.09.17 | Teva Pharmaceutical Industries Underperform | RBC Capital Markets | |
04.08.17 | Teva Pharmaceutical Industries Underperform | RBC Capital Markets | |
11.01.07 | Teva Pharmaceutical Industries sell | Jyske Bank | |
07.12.06 | Teva Pharmaceutical Industries sell | Jyske Bank | |
Werbung
|
|||
27.06.06 | Teva Pharmaceutical Industries verkaufen | Nasd@q Inside |
Werbung